Table: Cosmos Pharmaceutical -2022/23 group results

Cosmos Pharmaceutical

10/07/2023 07:00

Jul 10 (Reuters)- 
          Cosmos Pharmaceutical Corp. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              May 31, 2023    May 31, 2022   May 31, 2024     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          827.70          755.41         916.00        450.40   
               (+9.6 pct)                     (+10.7 pct)  (+11.5 pct) 
  Operating       30.13           29.80          30.20         14.10   
               (+1.1 pct)                     (+0.2 pct)    (-8.4 pct) 
  Recurring       33.09           32.86          33.20         15.60   
               (+0.7 pct)                     (+0.3 pct)    (-7.7 pct) 
  Net
  Net             23.80           23.16          23.80         10.58   
               (+2.8 pct)                     (+0.0 pct)    (-6.4 pct) 
  EPS          600.96 yen      584.76 yen     601.03 yen    267.10 yen 
  Ann Div      100.00 yen       80.00 yen     120.00 yen               
  -Q2 Div       42.50 yen       40.00 yen      60.00 yen               
  -Q4 Div       57.50 yen       40.00 yen      60.00 yen               
  
  NOTE - Cosmos Pharmaceutical Corp..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T